Carbidopa (Lodosyn) is a drug given to people with Parkinson’s disease in order to inhibit peripheral metabolism of levodopa. This property is significant in that it allows a greater proportion of peripheral levodopa to cross the blood brain barrier for central nervous system effect.
This page contains content from the copyrighted Wikipedia article "Carbidopa"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
